canreg is a company dedicated exclusively to regulatory affairs consulting for the pharmaceutical, biotechnology and medical device industries.  More than 100 in-house consultants and staff serve clients in the United States, Canada and Europe.  canreg is a one-stop global regulatory solution for companies of all sizes and at all stages of development. 

Contact Us

CanReg News
December 9, 2009
i3 Acquisition of CanReg

November 19, 2009
Listen to free recorded webinar: Seven Myths About Commercializing BioPharma Products in Canada

November 3-4, 2009
Anne Tomalin chairs a session on Orphan Drugs at Canadian DIA Meeting

Training Courses

Regulatory News
• Canada
• United States
• Europe